Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello there. Today, we learn the FDA is advancing a trial for gene-edited pig organs in humans, see geographical discrepancies in lung cancer trial data, and more.

The need-to-know this morning

A positive readout of a Rapport Therapeutics seizure medicine in a mid-stage clinical trial sent company shares soaring, as the biotech announced it would move the experimental drug into Phase 3 trials. Read more from STAT reporter Andrew Joseph.

Dianthus Therapeutics said its experimental treatment for myasthenia gravis achieved the primary goals of a Phase 2 study.

Pfizer and BioNTech reported top-line Phase 3 study results showing their Covid-19 vaccine

See Full Page